Johanna Matull Elisabeth Livingstone Axel Wetter Lisa Zimmer Anne Zaremba Harald Lahner Dirk Schadendorf Selma Ugurel
10.3389/fonc.2020.592609
Front Oncol
2020 Nov 11;10:592609.
case report checkpoint inhibitors immune-related adverse events melanoma therapy discontinuation
CC BY
https://pubmed.ncbi.nlm.nih.gov/33262949/
Case Reports
PMC7686558
33262949
Durable Complete Response in a Melanoma Patient With Unknown Primary, Associated With Sequential and Severe Multi-Organ Toxicity After a Single Dose of CTLA-4 Plus PD-1 Blockade: A Case Report
2020